Stephanie Laufs

A combination of granulocyte-colony-stimulating factor (G-CSF) and plerixafor mobilizes more primitive peripheral blood progenitor cells than G-CSF alone: results of a European phase II study

Stefan Früehauf, Marlon R. Veldwijk, Timon Seeger et al. · Cytotherapy · 2009 · 123 citations

Inflammation, Plerixafor Mobilizes, Granulocyte +10

Development and Optimization of a Real-Time Quantitative PCR-Based Method for the Titration of AAV-2 Vector Stocks

Marlon R. Veldwijk, Julian Topaly, Stephanie Laufs et al. · Molecular Therapy · 2002 · 108 citations · Full text

Retroviral vector integration occurs in preferred genomic targets of human bone marrow-repopulating cells

Stephanie Laufs · Blood · 2002 · 100 citations · Full text

Insertion of Retroviral Vectors in NOD/SCID Repopulating Human Peripheral Blood Progenitor Cells Occurs Preferentially in the Vicinity of Transcription Start Regions and in Introns

Stephanie Laufs, K. Zsuzsanna Nagy, Frank A. Giordano et al. · Molecular Therapy · 2004 · 89 citations · Full text

Viral Replication, Favored Integration, Genetics +16

Plerixafor inhibits chemotaxis toward SDF-1 and CXCR4-mediated stroma contact in a dose-dependent manner resulting in increased susceptibility of BCR-ABL⁺cell to Imatinib and Nilotinib

Falk Dillmann, Marlon R. Veldwijk, Stephanie Laufs et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2009 · 63 citations

Chemoprevention Strategy, Mixed-phenotype Acute Leukemia, Immunology +20